March 4th 2025
The biosimilars are expected to become available in the US in June 2025.
January 14th 2025
Recommendations have been largely preserved since 2018 and the USPSTF acknowledged the need for more research and better risk assessment tools.
December 3rd 2024
CT-P41 had similar rates of bone mineral density increases and adverse events in data presented at the ACR 2024 Convergence.
October 4th 2024
September 10th 2024
Fragility fractures occur every minute in France, totaling 500,000 annually. A report calls for expanding fracture liaison services to address the growing osteoporosis burden.
Making Important Clinical Decisions in Osteoporosis Management
Involving patients in decision making may help improve the quality of care.